| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| TZDs | Thiazolidinediones |
| DMF | Dimethylformamide |
| PTSA | Para-toluenesulfonic acid |
| Cs2 | Carbon disulfide |
| ANOVA | Analysis of Variance |
| SOCl2 | Thionyl chloride |
| DCM | Dichloromethane |
| PEG | Polyethylene Glycol-600 |
| POCl3 | Phosphorus oxychloride |
| EtOH | Ethanol |
| Nrf2 | Nuclear factor erythroid 2 |
| IBD | Inflammatory bowel disease |
| NASH | Non-alcoholic steatohepatitis |
| NAFLD | Non-alcoholic fatty liver disease |
| DMD | Duchenne muscular dystrophy |
| LGMD | Limb-girdle muscular dystrophy |
| BMD | Becker muscular dystrophy |
| GHR | Growth hormone receptor |
| STAT5 | Signal transduction/transcription activator 5 |
| sIBM | sporadic inclusion body myositis |
| TNF | Tumor necrosis factor |
| IL | Interleukin |
| AMY2A | Amylase alpha 2A |
| GAA | Glucosidase alpha, acid |
| PPARG | Peroxisome proliferator-activated receptor gamma |
| PIK3CA | Phosphatidylinositol 4,5-biphosophate 3-kinase catalytic subunit alpha |
| PRKCB | Protein kinase C beta |
| INSR | Insulin Receptor |
| EDG | Electron donating group |
| EWG | Electron withdrawing group |
| CALYX | Cerebral adrenoleukodystrophy |
| SGLT-2 | Sodium–glucose cotransport 2 |
| DPP-4 | Dipeptidyl peptidase-4 |
| PEP-DM | Pharmacophore enhanced pharmacodynamic modeling |
| CVD | Cardiovascular disease |